115 related articles for article (PubMed ID: 7453846)
21. [On the methodology of the determination of alkylating activities of nitrogen mustards with nitrobenzylpyridine (NBP) in biological material (author's transl)].
Hesse G; Schulze W; Wachtel E
Pharmazie; 1981 Sep; 36(9):609-12. PubMed ID: 7301901
[TBL] [Abstract][Full Text] [Related]
22. Influence of mustard group structure on pathways of in vitro metabolism of anticancer N-(2-hydroxyethyl)-3,5-dinitrobenzamide 2-mustard prodrugs.
Helsby NA; Goldthorpe MA; Tang MH; Atwell GJ; Smith EM; Wilson WR; Tingle MD
Drug Metab Dispos; 2008 Feb; 36(2):353-60. PubMed ID: 17998296
[TBL] [Abstract][Full Text] [Related]
23. Design and synthesis of a nitrogen mustard derivative stabilized by apo-neocarzinostatin.
Urbaniak MD; Bingham JP; Hartley JA; Woolfson DN; Caddick S
J Med Chem; 2004 Sep; 47(19):4710-5. PubMed ID: 15341486
[TBL] [Abstract][Full Text] [Related]
24. [Structure-activity relationship in Mannich bases with and without nitrogen mustard groups and in various reduction products derived from beta-aminoketones as evidenced with the aid of a cancerostatic 3-step test using transplantation tumors].
Werner W; Jungstand W; Gutsche W; Wohlrabe K
Pharmazie; 1977 Jun; 32(6):341-7. PubMed ID: 896938
[No Abstract] [Full Text] [Related]
25. Potent antitumor N-mustard derivatives of 9-anilinoacridine, synthesis and antitumor evaluation.
Bacherikov VA; Chou TC; Dong HJ; Chen CH; Lin YW; Tsai TJ; Su TL
Bioorg Med Chem Lett; 2004 Sep; 14(18):4719-22. PubMed ID: 15324894
[TBL] [Abstract][Full Text] [Related]
26. Potential anticancer agents. VII. Relationship between basicity of precursor unsubstituted amines and hydrolysis rate of corresponding aromatic nitrogen mustards.
Niculescu-Duvaz I; Botez G; Serban A
Neoplasma; 1970; 17(2):143-54. PubMed ID: 5425392
[No Abstract] [Full Text] [Related]
27. Molecular orbital calculations on tumour-inhibitory aniline mustards: QSARs.
Lewis DF
Xenobiotica; 1989 Feb; 19(2):243-51. PubMed ID: 2728496
[TBL] [Abstract][Full Text] [Related]
28. [Pharmacologic studies with trophosphamide (Ixoten), a new oxazaphosphorineoxide].
Brock N
Med Monatsschr; 1973 Sep; 27(9):390-4. PubMed ID: 4768197
[No Abstract] [Full Text] [Related]
29. Nitrogen Mustards as Anticancer Chemotherapies: Historic Perspective, Current Developments and Future Trends.
Diethelm-Varela B; Ai Y; Liang D; Xue F
Curr Top Med Chem; 2019; 19(9):691-712. PubMed ID: 30931858
[TBL] [Abstract][Full Text] [Related]
30. Toxicity and antineoplastic activity of asalei (ethyl ester of acetyl-sarcolysine-L-leucine).
Larionov LF; Bukharova IK; Shamaeva EM
Fed Proc Transl Suppl; 1966; 25(1):77-8. PubMed ID: 5215810
[No Abstract] [Full Text] [Related]
31. Evaluation of phthalmustine, a new anticancer compound. II. Tumor inhibitory effect in murine Ehrlich ascites carcinoma and sarcoma-180.
Bhattacharya S; Ghosh M; Sadhu U; Dutta S; Sanyal U
Neoplasma; 1996; 43(3):209-13. PubMed ID: 8841510
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of naphthalmustine, a nitrogen mustard derivative of naphthalimide as a rationally-designed anticancer agent.
Pain A; Samanta S; Dutta S; Saxena AK; Shanmugavel M; Kampasi H; Qazi GN; Sanyal U
J Exp Clin Cancer Res; 2003 Sep; 22(3):411-8. PubMed ID: 14582700
[TBL] [Abstract][Full Text] [Related]
33. The primary in vitro anticancer activity of "half-mustard type" phenothiazines in NCI's revised anticancer screening paradigm.
Wuonola MA; Palfreyman MG; Motohashi N; Kawase M; Gabay S; Gupta RR; Molnár J
Anticancer Res; 1998; 18(1A):337-48. PubMed ID: 9568100
[TBL] [Abstract][Full Text] [Related]
34. Antitumor activity of derivatives of nitrogen mustard containing a 2-chloroethyl group.
SAKURAI Y; SAWATARI K
Cancer Chemother Rep; 1961 Jul; 13():205-10. PubMed ID: 13745518
[No Abstract] [Full Text] [Related]
35. Nitracrine N-oxides: effects of variations in the nature of the side chain N-oxide on hypoxia-selective cytotoxicity.
Lee HH; Wilson WR; Denny WA
Anticancer Drug Des; 1999 Dec; 14(6):487-97. PubMed ID: 10834270
[TBL] [Abstract][Full Text] [Related]
36. Influence of the basicity and details of the chemical structure on the mutagenic activity of nitrogen mustards.
Kovalenko SP
Sov Genet; 1974 Oct; 8(11):1409-11. PubMed ID: 4445901
[No Abstract] [Full Text] [Related]
37. Experimental study on the antitumoral activity of some N-mustards derivatives of the L-asparagic acid.
Năstasă V; Sunel V; Dăneţ D; Dăneţ R
Rev Med Chir Soc Med Nat Iasi; 1983; 87(4):619-22. PubMed ID: 6676886
[No Abstract] [Full Text] [Related]
38. [Study of toxicity and anti-tumor activity of mixtures of bromine, iodine- and fluorine-containing di-2-halogenethylamines].
Demirchoglian IG; Babasian OV; Galstian DA
Zh Eksp Klin Med; 1974; 14(5):45-7. PubMed ID: 4460648
[No Abstract] [Full Text] [Related]
39. A study on immunological therapy for cancer by using nitrogen mustard-treated cancer tissue.
Asakuma R; Yokoyama I
Nihon Geka Hokan; 1965 Nov; 34(6):1413-29. PubMed ID: 5893249
[No Abstract] [Full Text] [Related]
40. [Mechanism of action of pafencil on sensitive and resistant tumor cells].
Ivanova LE; Kotel'nikov VM
Gematol Transfuziol; 1992 Mar; 37(3):37-9. PubMed ID: 1516801
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
